Keppra Safety Reports submitted to FDA
>>>Help Community - Review Your Keppra Side Effect Episode
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZTotal Keppra reports: 688.
Keppra FDA safety alerts: 2003 2008 .
Reported deaths: 84 Reported hospitalizations: 287.
Take Keppra Side Effects Survey, Discuss Keppra with others or
Add Your Side Effect to the Community Database
FDA Reported Keppra Side Effects: thrombocytopenia, condition aggravated, grand mal convulsion, fatigue, pregnancy with contraceptive device, depression, premature baby, pregnancy, abortion spontaneous, aggression, caesarean section.
Keppra Usage.
If you have questions about Keppra, you can ask a Health Expert or Ask Patient Community about Keppra.
< Previous Showing 301-400 of 688 Next >
Keppra Side Effects Report #5050427-2Consumer or non-health professional from GERMANY reported KEPPRA problem on June 21, 2006. Female patient, 44 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: amnesia, anxiety, complex regional pain syndrome, disease progression, loss of consciousness, status epilepticus. KEPPRA dosage: 1500 MG /D PO. During the same period patient was treated with CARBAMAZEPINE, OXYGESIC, CELECOXIB, VALPROATE. Patient died on 04/28/2006.
Keppra Side Effects Report #5050445-4
KEPPRA problem was reported by a Physician from UNITED KINGDOM on June 22, 2006. Female patient, 45 years of age, weighting 183.0 lb, was diagnosed with epilepsy, psychotic disorder, depression and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression, cerebral infarction, condition aggravated, convulsion, impaired self-care, myocardial ischaemia, weight increased. KEPPRA dosage: 2000 MG /D. During the same period patient was treated with TEGRETOL, ABILIFY, CIPRAMIL, KEMADRIN. Patient died on 06/10/2006.
Keppra Side Effects Report #5050446-6
Consumer or non-health professional from GERMANY reported KEPPRA problem on June 21, 2006. Male patient, weighting 119.0 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: dizziness, glomerular filtration rate increased, headache, leukopenia, ph urine increased, thrombocytopenia, viral infection. KEPPRA dosage: 500 MG 3/D. Patient recovered.
Keppra Side Effects Report #5050447-8
KEPPRA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 22, 2006. Female patient was diagnosed with temporal lobe epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: conversion disorder, depression, dizziness, grand mal convulsion, incorrect dose administered, insomnia, muscle twitching, somnolence. KEPPRA dosage: 2000 MG /D PO. During the same period patient was treated with TOPIRAMATE, SEROXAT. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5050448-X
Health Professional from GERMANY reported KEPPRA problem on June 23, 2006. Male patient, 82 years of age, was diagnosed with status epilepticus and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: status epilepticus. KEPPRA dosage: unknown. During the same period patient was treated with SEDATIVES. Patient was hospitalized. Patient died.
Keppra Side Effects Report #5050454-5
KEPPRA problem was reported by a Physician from GERMANY on June 22, 2006. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: cardiac failure acute, myocardial infarction, status epilepticus. KEPPRA dosage: 1500 MG IV. During the same period patient was treated with DIAZEPAM, PROPOFOL. Patient was hospitalized. Patient died.
Keppra Side Effects Report #5051507-8
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on June 27, 2006. Male patient, 42 years of age, was diagnosed with convulsion, agitation, depression and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, depression, dysstasia, lethargy, memory impairment, sedation, status epilepticus, traumatic brain injury. KEPPRA dosage: 1000 MG 2/D PO. During the same period patient was treated with ABILIFY, LEXAPRO, CARBATROL. Patient recovered.
Keppra Side Effects Report #5051508-X
KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2006. Female patient, 40 years of age, weighting 135.6 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: lower limb fracture. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with DILANTIN, CENTRUM, CALCIUM MAGNESIUM ZINC. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5051511-X
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on June 28, 2006. Female patient, 15 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, grand mal convulsion, therapeutic response decreased. KEPPRA dosage: 2000 MG/D PO. During the same period patient was treated with LAMICTAL, TRANXENE. Patient recovered.
Keppra Side Effects Report #5051640-0
KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2006. Female patient, weighting 40.08 lb, was diagnosed with petit mal epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, fatigue, incorrect dose administered. KEPPRA dosage: 1000 MG 2/D PO. During the same period patient was treated with RITALIN. Patient recovered.
Keppra Side Effects Report #5052022-8
Consumer or non-health professional from GERMANY reported KEPPRA problem on June 26, 2006. Female patient, child 3 years of age, weighting 26.46 lb, was diagnosed with partial seizures and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anuria, febrile infection, hepatic enzyme increased, urinary retention. KEPPRA dosage: 300 MG 2/D. During the same period patient was treated with OXCARBAZEPINE. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5052062-9
KEPPRA problem was reported by a Pharmacist from GERMANY on June 27, 2006. Female patient, 41 years of age, weighting 155.4 lb, was diagnosed with convulsion, epilepsy, partial seizures and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression, convulsion, muscle spasms, muscle spasticity, oedema. KEPPRA dosage: 1000 MG 2/D PO. During the same period patient was treated with ERGENYL CHRONO, ERGENYL CHRONO. Patient recovered.
Keppra Side Effects Report #5052146-5
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on July 12, 2006. Female patient, 35 years of age, weighting 150.0 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anxiety, bipolar disorder, depression, mania, muscle injury. KEPPRA dosage: 3000 MG DAY. Patient recovered.
Keppra Side Effects Report #5053255-7
KEPPRA problem was reported by a Physician from UNITED STATES on June 28, 2006. Male patient, weighting 5.73 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: acrochordon, complex partial seizures, dysmorphism, gestational diabetes, grand mal convulsion, gynaecological chlamydia infection, haemangioma, high arched palate. KEPPRA dosage: 750 MG TRP. During the same period patient was treated with PHENOBARBITAL, PRENATAL VITAMINS, ZITHROMAX, ZANTAC, VITAMIN K. Patient recovered.
Keppra Side Effects Report #5053256-9
Physician from UNITED STATES reported KEPPRA problem on June 28, 2006. Male patient, child 3 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: encephalitis viral, epistaxis, tremor. KEPPRA dosage: 225 MG 2/D PO. During the same period patient was treated with PHENOBARBITAL, ZONISAMIDE, DEPAKOTE. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5056069-7
KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on June 30, 2006. Female patient, 22 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. KEPPRA dosage: 1500 MG/D PO. During the same period patient was treated with CLARITIN. Patient recovered.
Keppra Side Effects Report #5056073-9
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on July 03, 2006. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: blood urine present, haemorrhage, pregnancy with contraceptive device, unintended pregnancy. KEPPRA dosage: unknown. During the same period patient was treated with MOXIFLOXACIN. Patient recovered.
Keppra Side Effects Report #5056074-0
KEPPRA problem was reported by a Physician from UNITED STATES on July 06, 2006. Male patient, 47 years of age, was diagnosed with convulsion, colitis and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abstains from alcohol, colitis, convulsion, diabetes mellitus inadequate control, haemorrhage, lipids abnormal, metabolic disorder, rash. KEPPRA dosage: 750 MG 2/D PO. During the same period patient was treated with MESALAMINE, CARBATROL. Patient recovered.
Keppra Side Effects Report #5056076-4
Physician from UNITED STATES reported KEPPRA problem on July 06, 2006. Female patient, weighting 26.46 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: convulsion, incorrect dose administered, platelet count increased, posture abnormal, pyrexia. KEPPRA dosage: 100 MG 2/D PO. During the same period patient was treated with PHENOBARBITAL, TOPAMAX. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5056098-3
KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Apr 28, 2006. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: unintended pregnancy. KEPPRA dosage: 500 MG/D. Patient recovered.
Keppra Side Effects Report #5056426-9
Consumer or non-health professional from GERMANY reported KEPPRA problem on July 04, 2006. Male patient, 31 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, partial seizures, somnolence, vomiting. KEPPRA dosage: 2500 MG/D. During the same period patient was treated with ERGENYL, TIMOX D. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5060037-9
KEPPRA problem was reported by a Health Professional from UNITED STATES on July 03, 2006. Female patient, 21 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion induced, pregnancy. KEPPRA dosage: 1000 MG /D PO. Patient recovered.
Keppra Side Effects Report #5062161-3
Physician from UNITED STATES reported KEPPRA problem on July 10, 2006. Female patient was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, cardiac murmur, cephalhaematoma, pulmonary artery stenosis, upper respiratory tract infection, vomiting. KEPPRA dosage: 1000 MG /D TRP. During the same period patient was treated with PRENATAL VITAMINS, HEMOCYTE. Patient recovered.
Keppra Side Effects Report #5062287-4
KEPPRA problem was reported by a Consumer or non-health professional from ITALY on July 07, 2006. Male patient, 74 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with TENORMIN, DICUMAROL. Patient recovered.
Keppra Side Effects Report #5062288-6
Consumer or non-health professional from GERMANY reported KEPPRA problem on July 07, 2006. Female patient, child 3 years of age, weighting 26.46 lb, was diagnosed with partial seizures and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, febrile infection, hepatic enzyme increased, urinary retention, urinary tract obstruction. KEPPRA dosage: 300 MG 2/D. During the same period patient was treated with OXCARBAZEPINE. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5062467-8
KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on July 10, 2006. Male patient, 20 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: leukopenia. KEPPRA dosage: 1800 MG / D. Patient recovered.
Keppra Side Effects Report #5066584-8
Physician from UNITED STATES reported KEPPRA problem on Feb 06, 2006. Male patient, weighting 16.31 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: caesarean section, developmental delay, placenta praevia. KEPPRA dosage: unknown. During the same period patient was treated with LEXAPRO, SEROQUEL, ASPIRIN, PRENATAL VITAMINS. Patient recovered.
Keppra Side Effects Report #5072910-6
KEPPRA problem was reported by a Health Professional from GERMANY on July 20, 2006. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion induced, anencephaly. KEPPRA dosage: unknown. During the same period patient was treated with OXCARBAZEPINE. Patient recovered.
Keppra Side Effects Report #5072920-9
Physician from GERMANY reported KEPPRA problem on July 17, 2006. Male patient, 66 years of age, weighting 154.3 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: status epilepticus. KEPPRA dosage: unknown. Patient died on 07/16/2006.
Keppra Side Effects Report #5072921-0
KEPPRA problem was reported by a Health Professional from GERMANY on July 20, 2006. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion, congenital anomaly, foetal cardiac disorder. KEPPRA dosage: unknown. Patient died.
Keppra Side Effects Report #5072922-2
Health Professional from GERMANY reported KEPPRA problem on July 20, 2006. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion. KEPPRA dosage: 4000 MG /D. Patient recovered.
Keppra Side Effects Report #5072923-4
KEPPRA problem was reported by a Physician from CZECH REPUBLIC on July 20, 2006. Female patient, 31 years of age, weighting 127.9 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: petit mal epilepsy, unintended pregnancy. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with TEGRETOL. Patient recovered.
Keppra Side Effects Report #5072924-6
Physician from GERMANY reported KEPPRA problem on July 17, 2006. Female patient, 74 years of age, weighting 165.3 lb, was diagnosed with partial seizures, encephalitis viral and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, arrhythmia, cardiac failure acute, diabetic hyperosmolar coma, encephalitis viral, partial seizures. KEPPRA dosage: 1500 MG 2/D IV. During the same period patient was treated with ACYCLOVIR, UNACID, TAVOR, MIDAZOLAM HYDROCHLORIDE. Patient died on 06/19/2006.
Keppra Side Effects Report #5072925-8
KEPPRA problem was reported by a Health Professional from GERMANY on July 20, 2006. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion, anencephaly. KEPPRA dosage: unknown. During the same period patient was treated with OXCARBAZEPINE. Patient died.
Keppra Side Effects Report #5073100-3
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on July 18, 2006. Female patient, 27 years of age, was diagnosed with grand mal convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: brain operation, grand mal convulsion. KEPPRA dosage: 2000 MG / D PO. During the same period patient was treated with PRILOSEC, LYRICA. Patient recovered.
Keppra Side Effects Report #5073101-5
KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient, 31 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KEPPRA dosage: 2000 MG PO. During the same period patient was treated with SYNTHROID, FOLIC ACID, PRENATAL VITAMINS. Patient recovered.
Keppra Side Effects Report #5074788-3
Physician from FRANCE reported KEPPRA problem on July 21, 2006. Male patient, child 3 years of age, weighting 22.05 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: coma, depressed level of consciousness, hypotonia. KEPPRA dosage: 100 MG 2/D. During the same period patient was treated with PHENOBARBITAL, ALDACTONE, LASILIX. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5074789-5
KEPPRA problem was reported by a Physician from FRANCE on July 21, 2006. Female patient, child 7 years of age, was diagnosed with epilepsy, infantile spasms and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: coma, overdose. KEPPRA dosage: unknown. During the same period patient was treated with PHENOBARBITAL. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5074790-1
Pharmacist from CANADA reported KEPPRA problem on July 27, 2006. Female patient, 50 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, depressed level of consciousness, leukopenia, overdose, suicide attempt, thrombocytopenia. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with CARBAMAZEPINE, VALPROIC ACID, VALPROIC ACID, DILANTIN. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5075242-5
KEPPRA problem was reported by a Physician from UNITED STATES on July 24, 2006. Female patient, 22 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KEPPRA dosage: 1000 MG /D PO. During the same period patient was treated with LYRICA, SYNTHROID, NOVALOG. Patient recovered.
Keppra Side Effects Report #5075243-7
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on July 24, 2006. Female patient, 52 years of age, was diagnosed with grand mal convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, cerebrovascular accident, grand mal convulsion, treatment noncompliance. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with DILANTIN, AMITRIPTYLINE. Patient was hospitalized. Patient died on 07/01/2006.
Keppra Side Effects Report #5075252-8
KEPPRA problem was reported by a Physician from UNITED STATES on July 24, 2006. Male patient, weighting 8.29 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: feeding disorder neonatal, grunting, jaundice neonatal, nasal flaring, neonatal respiratory distress syndrome. KEPPRA dosage: 2000 MG /D TRP. During the same period patient was treated with PRENATAL VITAMINS. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5078681-1
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Aug 09, 2006. Female patient, 22 years of age, weighting 165.0 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, hallucination, auditory, hallucination, visual, obsessive thoughts, suicidal ideation, thinking abnormal. KEPPRA dosage: 2000 MG BID PO. Patient recovered.
Keppra Side Effects Report #5080699-X
KEPPRA problem was reported by a Pharmacist from CANADA on July 24, 2006. Female patient, 73 years of age, weighting 189.6 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree, atrioventricular block third degree. KEPPRA dosage: 938 MG PO. During the same period patient was treated with TYLENOL, KEFZOL, FLAGYL I, DILAUDID, GRAVOL. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5080825-2
Health Professional from GERMANY reported KEPPRA problem on July 25, 2006. Male patient, 20 years of age, weighting 66.14 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: femur fracture, osteoporosis. KEPPRA dosage: 625 MG. During the same period patient was treated with TEGRETOL. Patient recovered.
Keppra Side Effects Report #5080897-5
KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on July 26, 2006. Female patient, 87 years of age, weighting 127.9 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, hepatitis toxic. KEPPRA dosage: 2000 MG /D PO. During the same period patient was treated with NEURONTIN, BELOK, PLAVIX, DELIX PLUS. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5080899-9
Consumer or non-health professional from FRANCE reported KEPPRA problem on July 25, 2006. Female patient, 45 years of age, was diagnosed with epilepsy, depression and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, vitamin b1 decreased, vitamin b6 decreased, wernicke's encephalopathy. KEPPRA dosage: unknown. During the same period patient was treated with DEPAKENE, VALIUM, SELOKEN. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5081207-X
KEPPRA problem was reported by a Physician from UNITED STATES on Aug 04, 2006. Male patient, weighting 12.90 lb, was diagnosed with infantile spasms and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: alopecia, incorrect dose administered. KEPPRA dosage: 450 MG 3/D PO. During the same period patient was treated with FELBATOL. Patient recovered.
Keppra Side Effects Report #5081660-1
Health Professional from GERMANY reported KEPPRA problem on July 28, 2006. Male patient, 25 years of age, weighting 176.4 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, fatigue, intentional overdose, urinary retention. KEPPRA dosage: 10000 MG ONCE PO. During the same period patient was treated with CARBAMAZEPINE. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5081943-5
KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on July 28, 2006. Male patient, 31 years of age, weighting 101.4 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression, anger, condition aggravated, convulsion, grand mal convulsion, partial seizures, psychomotor seizures, somnolence, vomiting. KEPPRA dosage: 3500 MG /D PO. During the same period patient was treated with TIMOX. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5083307-7
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Aug 02, 2006. Female patient, child 7 years of age, weighting 48.06 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: sinus tachycardia. KEPPRA dosage: 50 MG /D PO. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5084144-X
KEPPRA problem was reported by a Physician from UNITED STATES on July 31, 2006. Female patient, 23 years of age, weighting 136.0 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, blood urine, ectopic pregnancy, haemorrhage, unintended pregnancy. KEPPRA dosage: 500 MG/ D PO. During the same period patient was treated with MOXIFLOXACIN. Patient recovered.
Keppra Side Effects Report #5085360-3
Consumer or non-health professional from GERMANY reported KEPPRA problem on Aug 02, 2006. Female patient, 36 years of age, weighting 121.3 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: accidental exposure. KEPPRA dosage: 1500 MG ONCE PO. During the same period patient was treated with CARBAMAZEPINE, ZYPREXA. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5085361-5
KEPPRA problem was reported by a Consumer or non-health professional from MEXICO on Aug 01, 2006. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: foetal movements decreased. KEPPRA dosage: unknown. Patient recovered.
Keppra Side Effects Report #5085863-1
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Aug 01, 2006. Male patient, 37 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression, homicidal ideation, psychotic disorder. KEPPRA dosage: 750 MG 2/D PO. During the same period patient was treated with DECADRON. Patient recovered.
Keppra Side Effects Report #5087201-7
KEPPRA problem was reported by a Health Professional from FRANCE on Aug 04, 2006. Male patient, 17 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: asthenia, complex partial seizures, cough, dehydration, dyspnoea, fatigue, obstructive airways disorder. KEPPRA dosage: unknown. During the same period patient was treated with EPITOMAX, TEGRETOL. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5087909-3
Physician from UNITED STATES reported KEPPRA problem on Aug 23, 2006. Female patient, 49 years of age, weighting 156.0 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: depression, suicidal ideation. KEPPRA dosage: 1000 MG BID PO. During the same period patient was treated with PREMARIN, ALBUTEROL. Patient recovered.
Keppra Side Effects Report #5089723-1
KEPPRA problem was reported by a Health Professional from GERMANY on Aug 11, 2006. Female patient, 22 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: acidosis, convulsion, fall, hemiparesis, hepatic failure, hepatic necrosis, hepatocellular damage, hypotension, pulmonary oedema. KEPPRA dosage: 1000 MG/DAY. During the same period patient was treated with TEGRETOL. Patient was hospitalized. Patient died.
Keppra Side Effects Report #5090213-0
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Aug 08, 2006. Male patient, 53 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. KEPPRA dosage: unknown. During the same period patient was treated with VALPROIC ACID, LAMICTAL. Patient recovered.
Keppra Side Effects Report #5090795-9
KEPPRA problem was reported by a Health Professional from SWEDEN on Aug 07, 2006. Male patient, 51 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, wound. KEPPRA dosage: 500 MG /D PO. During the same period patient was treated with LAMICTAL, ATACAND, GLUCOPHAGE, TROMBYL. Patient recovered.
Keppra Side Effects Report #5090941-7
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Aug 07, 2006. Male patient, 69 years of age, weighting 149.9 lb, was diagnosed with convulsion prophylaxis and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: agitation, amnesia, confusional state, fatigue, liver disorder, paranoia, urinary tract infection, weight decreased. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with HYDRALAZINE, ISOSORBIDE DINITRATE, COREG, LASIX, NEXIUM, ASPIRIN, SENOKOT. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5091717-7
KEPPRA problem was reported by a Consumer or non-health professional from MEXICO on Aug 08, 2006. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: foetal movements decreased. KEPPRA dosage: unknown. During the same period patient was treated with VALPROATE, LAMOTRIGINE. Patient recovered.
Keppra Side Effects Report #5092080-8
Health Professional from GERMANY reported KEPPRA problem on Aug 10, 2006. Male patient, 36 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: neutropenia, platelet count decreased. KEPPRA dosage: 1500 MG/D PO. During the same period patient was treated with GABAPENTIN, TRAMADOL, LORAZEPAM. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5092084-5
KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Aug 11, 2006. Female patient, 76 years of age, weighting 143.3 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: asthenia, treatment noncompliance. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with LAMICTAL, MYLEPSIN. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5092085-7
Physician from GERMANY reported KEPPRA problem on Aug 09, 2006. Female patient, 19 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: caesarean section, unintended pregnancy. KEPPRA dosage: unknown. During the same period patient was treated with VALPROATE, FOLIC ACID. Patient recovered.
Keppra Side Effects Report #5092163-2
KEPPRA problem was reported by a Health Professional from UNITED STATES on Aug 10, 2006. Female patient, 36 years of age, was diagnosed with epilepsy, depression, somnolence and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: placenta praevia, pregnancy. KEPPRA dosage: 1000 MG/D PO. During the same period patient was treated with LEXAPRO, SEROQUEL, ASPIRIN, PRENATAL VITAMINS. Patient recovered.
Keppra Side Effects Report #5092166-8
Physician from UNITED STATES reported KEPPRA problem on Aug 10, 2006. Male patient, weighting 16.31 lb, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: caesarean section, placenta praevia, premature baby. KEPPRA dosage: unknown. During the same period patient was treated with LEXAPRO. Patient recovered.
Keppra Side Effects Report #5095405-2
KEPPRA problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Female patient, 54 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. KEPPRA dosage: unknown. Patient recovered.
Keppra Side Effects Report #5095406-4
Physician from UNITED STATES reported KEPPRA problem on Aug 14, 2006. Female patient, 24 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, abortion threatened, pregnancy. KEPPRA dosage: 1000 MG 1/D PO. During the same period patient was treated with LAMICTAL, PRENATAL VITAMINS, FOLATE. Patient recovered.
Keppra Side Effects Report #5095407-6
KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Male patient, 52 years of age, was diagnosed with brain neoplasm malignant and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: anxiety, asthenia, confusional state, coordination abnormal, delusion, dizziness, gait disturbance, hallucination, panic attack. KEPPRA dosage: 1000 MG 2/D PO. During the same period patient was treated with DEXAMETHASONE, PREVACID, LEVOTHYROXINE, FLOMAX, HYDROCODONE BITARTRATE. Patient recovered.
Keppra Side Effects Report #5096476-X
Consumer or non-health professional from GERMANY reported KEPPRA problem on Aug 14, 2006. Male patient, child 7 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, convulsion, coordination abnormal, dyspepsia, fear, flatulence, gastrointestinal motility disorder, hostility. KEPPRA dosage: unknown. During the same period patient was treated with VALPROATE. Patient recovered.
Keppra Side Effects Report #5124258-9
KEPPRA problem was reported by a Health Professional from UNITED STATES on June 20, 2006. Female patient was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: convulsion, grip strength decreased, hypotonia, viral infection. KEPPRA dosage: 50 MG 2/D PO. During the same period patient was treated with LAMICTAL. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5097776-X
Physician from AUSTRALIA reported KEPPRA problem on Aug 18, 2006. Male patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, partial seizures. KEPPRA dosage: 500 MG 2/D. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5097777-1
KEPPRA problem was reported by a Consumer or non-health professional from GERMANY on Aug 17, 2006. Male patient, 71 years of age, weighting 165.3 lb, was diagnosed with apallic syndrome, epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, convulsion, dehydration, diarrhoea, urinary tract infection. KEPPRA dosage: 1000 MG 3/D PO. During the same period patient was treated with ZENTROPHIL. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5098908-X
Physician from UNITED STATES reported KEPPRA problem on Aug 18, 2006. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: headache, pregnancy. KEPPRA dosage: 1000 MG TRP. Patient recovered.
Keppra Side Effects Report #5099562-3
KEPPRA problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Male patient, weighting 15.21 lb, was diagnosed with hypersensitivity, depression, somnolence, anaemia, prenatal care and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: adrenogenital syndrome, arnold-chiari malformation, premature baby. KEPPRA dosage: 2000 MG TRP. During the same period patient was treated with ZYRTEC, DILANTIN, PAXIL, SEROQUEL, CITRUCEL, FOLIC ACID, FOLIC ACID. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5100765-X
Consumer or non-health professional from UNITED KINGDOM reported KEPPRA problem on Aug 21, 2006. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, epilepsy, neutropenia, rash macular, ulcer haemorrhage. KEPPRA dosage: 1000 MG 1/D PO. During the same period patient was treated with EPILIM, PHENYTOIN. Patient recovered.
Keppra Side Effects Report #5102009-1
KEPPRA problem was reported by a Physician from UNITED STATES on Aug 22, 2006. Male patient, weighting 6.61 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: alpha 1 foetoprotein increased, apgar score low, blood human chorionic gonadotropin decreased, congenital anomaly, in vitro fertilisation, neural tube defect, oestriol decreased, single umbilical artery. KEPPRA dosage: 200 MG /D TRP. During the same period patient was treated with LAMOTRIGINE, PROTONIX, ZOLOFT, GLUCOPHAGE, PRENATAL VITAMINS, FOLIC ACID, HEPARIN, PROGESTERONE. Patient recovered.
Keppra Side Effects Report #5102587-2
Physician from UNITED STATES reported KEPPRA problem on Aug 22, 2006. Female patient was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: respiratory disorder neonatal. KEPPRA dosage: unknown. Patient recovered.
Keppra Side Effects Report #5103976-2
KEPPRA problem was reported by a Physician from GERMANY on Aug 25, 2006. Male patient, 44 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: anxiety, paranoia, psychomotor hyperactivity, psychotic disorder. KEPPRA dosage: 1500 MG 2/D. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5105303-3
Health Professional from GERMANY reported KEPPRA problem on Aug 28, 2006. Male patient, 20 years of age, weighting 66.14 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: bone operation, epilepsy, femur fracture, osteoporosis, pathological fracture, underweight. KEPPRA dosage: 625 MG. During the same period patient was treated with TEGRETOL. Patient recovered.
Keppra Side Effects Report #5105304-5
KEPPRA problem was reported by a Physician from AUSTRALIA on Aug 29, 2006. Male patient, 64 years of age, weighting 176.4 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block third degree, dizziness, malaise. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with CARBAMAZEPINE. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5109677-9
Physician from UNITED KINGDOM reported KEPPRA problem on Sept 01, 2006. Female patient was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: collapse of lung, dysphagia, status epilepticus. KEPPRA dosage: 1750 MG 2/D PO. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5109679-2
KEPPRA problem was reported by a Consumer or non-health professional from FRANCE on Aug 31, 2006. Female patient, 57 years of age, was diagnosed with hypoxia, myoclonus and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acne, amnesia, asthenia, bulimia nervosa, homicidal ideation, psychomotor hyperactivity, rash pruritic, suicidal ideation. KEPPRA dosage: 500 MG 2/D PO. During the same period patient was treated with RIVOTRIL, NOOTROPYL, LEVOTONINE. Patient recovered.
Keppra Side Effects Report #5109680-9
Physician from FRANCE reported KEPPRA problem on Aug 31, 2006. Female patient, 23 years of age, weighting 176.4 lb, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, pregnancy. KEPPRA dosage: unknown. During the same period patient was treated with URBANYL, LAMICTAL, SPECIAFOLDINE. Patient died on 05/22/2006.
Keppra Side Effects Report #5110567-6
KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Female patient, 49 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: convulsion, fall, fatigue, hypersomnia, loss of consciousness, petit mal epilepsy. KEPPRA dosage: 500 MG PO. During the same period patient was treated with KLONOPIN, ELAVIL, PROZAC, DEXADRIN, VICODIN. Patient recovered.
Keppra Side Effects Report #5110572-X
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Aug 30, 2006. Male patient, 37 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression, homicidal ideation, psychotic disorder. KEPPRA dosage: 750 MG 2/D PO. During the same period patient was treated with DECADRON. Patient recovered.
Keppra Side Effects Report #5110856-5
KEPPRA problem was reported by a Physician from UNITED STATES on Aug 31, 2006. Male patient, 20 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, diarrhoea, leukopenia. KEPPRA dosage: unknown. During the same period patient was treated with VALPROIC ACID. Patient recovered.
Keppra Side Effects Report #5110857-7
Physician from UNITED STATES reported KEPPRA problem on Sept 01, 2006. Female patient, 29 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: premature labour. KEPPRA dosage: 3000 MG/D. During the same period patient was treated with PLAQUENIL, PRENATAL VITAMINS, FOLIC ACID, LEXAPRO, CLONAZEPAM, TRILEPTAL. Patient recovered.
Keppra Side Effects Report #5113256-7
KEPPRA problem was reported by a Physician from UNITED STATES on Sept 06, 2006. Female patient, 29 years of age, was diagnosed with convulsion prophylaxis and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. KEPPRA dosage: 1000 MG/D PO. During the same period patient was treated with VITAMIN. Patient recovered.
Keppra Side Effects Report #5113262-2
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Sept 06, 2006. Female patient, child 11 years of age, weighting 185.2 lb, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: aggression, anger, crying, insomnia, petit mal epilepsy, screaming, suicidal ideation. KEPPRA dosage: 500 MG/D/ PO. During the same period patient was treated with ZARONTIN. Patient recovered.
Keppra Side Effects Report #5113555-9
KEPPRA problem was reported by a Physician from GERMANY on Sept 07, 2006. Male patient, 82 years of age, was diagnosed with status epilepticus and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: cardiac failure, pneumonia, sepsis. KEPPRA dosage: unknown. During the same period patient was treated with SEDATIVES. Patient was hospitalized. Patient died.
Keppra Side Effects Report #5113865-5
Consumer or non-health professional from UNITED STATES reported KEPPRA problem on Sept 05, 2006. Female patient, 56 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: alopecia, chronic lymphocytic leukaemia stage 0, hair texture abnormal, hypotrichosis. KEPPRA dosage: 750 MG 2/D PO. During the same period patient was treated with HORMONE PREPARATION, AVAPRO, CLARITIN, PRILOSEC. Patient recovered.
Keppra Side Effects Report #5115389-8
KEPPRA problem was reported by a Physician from AUSTRALIA on Sept 06, 2006. Male patient, 21 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, alcohol use, amnesia, blood bicarbonate decreased, blood calcium decreased, hepatic failure, hepatic necrosis. KEPPRA dosage: unknown. During the same period patient was treated with OXCARBAZEPINE. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5117429-9
Physician from UNITED STATES reported KEPPRA problem on Sept 12, 2006. Female patient was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, cardiac murmur, cephalhaematoma, congenital cardiovascular anomaly, maternal condition affecting foetus, pulmonary artery stenosis, upper respiratory tract infection, vomiting. KEPPRA dosage: 1000 MG/D TRP. During the same period patient was treated with PRENATAL VITAMINS, HEMOCYTE. Patient recovered.
Keppra Side Effects Report #5117431-7
KEPPRA problem was reported by a Physician from UNITED STATES on Sept 11, 2006. Female patient, 33 years of age, was diagnosed with grand mal convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: antepartum haemorrhage, caesarean section, fall, grand mal convulsion, lower limb fracture, vaginal haemorrhage. KEPPRA dosage: 1000 MG/D PO. During the same period patient was treated with PHENYTOIN, PRENATAL VITAMINS, CALCIUM GLUCONATE, FOLIC ACID. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5117434-2
Physician from UNITED STATES reported KEPPRA problem on Sept 12, 2006. Male patient, 14 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: schizophrenia. KEPPRA dosage: unknown. Patient recovered.
Keppra Side Effects Report #5118192-8
KEPPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 15, 2006. Female patient, 52 years of age, was diagnosed with epilepsy, urinary tract infection and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: body temperature increased, condition aggravated, convulsion, fall, hypotension, incorrect dose administered, rash. KEPPRA dosage: 1500 MG 2/D PO. During the same period patient was treated with LEVAQUIN, DILANTIN. Patient was hospitalized. Patient recovered.
Keppra Side Effects Report #5118964-X
Physician from IRELAND reported KEPPRA problem on Sept 13, 2006. Female patient, 75 years of age, was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. KEPPRA dosage: unknown. Patient recovered.
Keppra Side Effects Report #5120019-5
KEPPRA problem was reported by a Pharmacist from UNITED KINGDOM on Sept 14, 2006. Female patient, child 3 years of age, was diagnosed with epilepsy and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: unevaluable event. KEPPRA dosage: unknown. During the same period patient was treated with VALPROATE. Patient was hospitalized. Patient recovered.
< Previous Showing 301-400 of 688 Next >
Drug Information: Levetiracetam
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a699059.html
(lee ve tye ra' se tam)IMPORTANT WARNING:
| [Posted 01/31/2008] FDA informed healthcare professionals that the Agency has analyzed reports of suicidality (suicidal behavior or ideation) from placebo-controlled clinical studies of eleven drugs used to treat epilepsy as well as psychiatric disorders, and other conditions. In the FDA's analysis, patients receiving antiepileptic drugs had approximately twice the risk of suicidal behavior or ideation (0.43%) compared to patients receiving placebo (0.22%). The increased risk of suicidal behavior and suicidal ideation was observed as early as one week after starting the antiepileptic drug and continued through 24 weeks. The results were generally consistent among the eleven drugs. The relative risk for suicidality was higher in patients with epilepsy compared to patients who were given one of the drugs in the class for psychiatric or other conditions.Healthcare professionals should closely monitor all patients currently taking or starting any antiepileptic drug for notable changes in behavior that could indicate the emergence or worsening of suicidal thoughts or behavior or depression.The drugs included in the analyses include (some of these drugs are also available in generic form): Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR)Felbamate (marketed as Felbatol)Gabapentin (marketed as Neurontin) Lamotrigine (marketed as Lamictal) Levetiracetam (marketed as Keppra) Oxcarbazepine (marketed as Trileptal)Pregabalin (marketed as Lyrica) Tiagabine (marketed as Gabitril)Topiramate (marketed as Topamax) Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) Zonisamide (marketed as Zonegran) Although the 11 drugs listed above were the ones included in the analysis, FDA expects that the increased risk of suicidality is shared by all antiepileptic drugs and anticipates that the class labeling changes will be applied broadly. For more information visit the FDA website at: http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antiepileptic and http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. |
Why is this medication prescribed?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Levetiracetam is used in combination with other medications to treat certain types of seizures in people with epilepsy. Levetiracetam is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
How should this medicine be used?
Levetiracetam comes as a solution (liquid) and a tablet to take by mouth. It is usually taken twice a day, once in the morning and once at night, with or without food. Try to take levetiracetam at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take levetiracetam exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow the tablets whole; do not split, chew, or crush them.
If you are taking the oral solution, do not use a household spoon to measure your dose. You might not get the right amount of medication. Ask your doctor or pharmacist to recommend a medicine dropper, spoon, cup, or syringe and to show you how to use it to measure your medication.
Your doctor may start you on a low dose of levetiracetam and gradually increase your dose, not more often than once every 2 weeks.
Levetiracetam controls epilepsy but does not cure it. Continue to take levetiracetam even if you feel well. Do not stop taking levetiracetam without talking to your doctor. If you suddenly stop taking levetiracetam, your seizures may become worse. Your doctor will probably decrease your dose gradually.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Before taking levetiracetam,
- tell your doctor and pharmacist if you are allergic to levetiracetam or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have or have ever had kidney disease.
- tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while taking levetiracetam, call your doctor. Do not breastfeed while you are taking levetiracetam
- you should know that levetiracetam may make you dizzy or drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
If it has only been a few hours since the time you were scheduled to take the dose, take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Levetiracetam may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- drowsiness
- weakness
- unsteady walking
- coordination problems
- headache
- pain
- forgetfulness
- anxiety
- agitation or hostility
- dizziness
- moodiness
- nervousness
- numbness, burning, or tingling in the hands or feet
- loss of appetite
- vomiting
- diarrhea
- constipation
- changes in skin color
Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:
- depression
- hallucinating (hearing voices or seeing visions that do not exist)
- thoughts of killing yourself
- seizures that are worse or different than the seizures you had before
- fever, sore throat, and other signs of infection
- double vision
- itching
- rash
- swelling of the face
Levetiracetam may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- drowsiness
- agitation
- aggression
- decreased consciousness or loss of consciousness
- difficulty breathing
What other information should I know?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Keep all appointments with your doctor.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
Ask Our Patient Community about Keppra |
||
|
|
||
|
|
||